Talal AH - Search Results

1

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.

Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez J, Bonilla H, Galpin J, Aberg JA, Johnston B, Glesby MJ, Jacobson IM. Talal AH, et al. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):261-8. doi: 10.1097/QAI.0b013e3182324af9. J Acquir Immune Defic Syndr. 2011. PMID: 21876446 Free PMC article. Clinical Trial.

2

Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue.

Talal AH, Monard S, Vesanen M, Zheng Z, Hurley A, Cao Y, Fang F, Smiley L, Johnson J, Kost R, Markowitz MH. Talal AH, et al. J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):1-7. doi: 10.1097/00126334-200101010-00001. J Acquir Immune Defic Syndr. 2001. PMID: 11176263 Clinical Trial.

3

Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue.

Talal AH, Irwin CE, Dieterich DT, Yee H, Zhang L. Talal AH, et al. J Acquir Immune Defic Syndr. 2001 Mar 1;26(3):208-17. doi: 10.1097/00042560-200103010-00002. J Acquir Immune Defic Syndr. 2001. PMID: 11242193

4

The HCV and HIV coinfected patient: what have we learned about pathophysiology?

Talal AH, Canchis PW, Jacobson I. Talal AH, et al. Curr Gastroenterol Rep. 2002 Feb;4(1):15-22. doi: 10.1007/s11894-002-0033-z. Curr Gastroenterol Rep. 2002. PMID: 11825537 Review.

5

Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.

Ni J, Hembrador E, Di Bisceglie AM, Jacobson IM, Talal AH, Butera D, Rice CM, Chambers TJ, Dustin LB. Ni J, et al. Among authors: talal ah. J Immunol. 2003 Mar 15;170(6):3429-39. doi: 10.4049/jimmunol.170.6.3429. J Immunol. 2003. PMID: 12626604

6

Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications.

Gonzalez SA, Talal AH. Gonzalez SA, et al. Among authors: talal ah. Semin Liver Dis. 2003 May;23(2):149-66. doi: 10.1055/s-2003-39946. Semin Liver Dis. 2003. PMID: 12800068 Review.

7

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM. Longman RS, et al. Among authors: talal ah. Blood. 2004 Feb 1;103(3):1026-9. doi: 10.1182/blood-2003-04-1339. Epub 2003 Oct 2. Blood. 2004. PMID: 14525790 Free article.

8

Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.

Talal AH, Shata MT, Markatou M, Dorante G, Chadburn A, Koch R, Neumann AU, Ribeiro RM, Perelson AS. Talal AH, et al. J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):103-13. doi: 10.1097/00126334-200402010-00001. J Acquir Immune Defic Syndr. 2004. PMID: 14722440

9

Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.

Wilfredo Canchis P, Gonzalez SA, Isabel Fiel M, Chiriboga L, Yee H, Edlin BR, Jacobson IM, Talal AH. Wilfredo Canchis P, et al. Among authors: talal ah. Liver Int. 2004 Jun;24(3):198-203. doi: 10.1111/j.1478-3231.2004.00907.x. Liver Int. 2004. PMID: 15189269

10

CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.

Lin AW, Gonzalez SA, Cunningham-Rundles S, Dorante G, Marshall S, Tignor A, Ha C, Jacobson IM, Talal AH. Lin AW, et al. Among authors: talal ah. Clin Exp Immunol. 2004 Aug;137(2):408-16. doi: 10.1111/j.1365-2249.2004.02523.x. Clin Exp Immunol. 2004. PMID: 15270860 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page